Interview with Selwyn Kahanovitz, CEO, Litha Healthcare Group Limited
Mr Kahanovitz, Focus Reports came to South Africa in 2005 to produce a similar report on the South African pharmaceutical industry. Could you come back for us on the main…
Address: No 106, 16th Road, Midrand, 1686, Gauteng, South Africa
Tel: +27 11 516 1700
Web: http://www.lithahealthcare.co.za/
Litha Healthcare Group Limited is the result of the successful acquisition by Myriad Medical Holdings of Litha Healthcare Holdings (Proprietary) Limited in 2010.
Litha is a diversified healthcare company, with headquarters in Johannesburg, South Africa. Established in 1992 and with over 340 employees nationally, we are the only truly diversified Healthcare group listed on the Johannesburg Stock Exchange.
Litha Healthcare Group is divided into three Divisions;
Litha Biotech
Litha Medical
Litha Pharma
Within each Division there are 100% owned business units with the exception of The Biovac Institute which is a Public Private Partnership (PPP) between the SA Government and The Biovac Consortium.
Each Division is lead by a Divisional CEO. Litha Healthcare Group Limited provides healthcare solutions to hospitals, clinics, specialists pharmacies and general and allied practitioners either through distribution networks or directly.
The group’s diversified businesses include the following areas of healthcare:
Biotechnology : Vaccines
Medical devices : Consumables and Equipment
Pharmaceuticals : Generic, Ethical and Complimentary
Mr Kahanovitz, Focus Reports came to South Africa in 2005 to produce a similar report on the South African pharmaceutical industry. Could you come back for us on the main…
The country president for South Africa & Sub-Saharan Africa at AstraZeneca reveals why AstraZeneca sees Africa as the next frontier within the pharmaceutical industry, how their Research Trust looks to…
The head of pharma for Bayer Southern Africa reveals how South Africa plays a key role in Bayer’s African strategy, with more than 60 percent of the continent’s total sales,…
The CEO of Pharma Dynamics explains why the company was the perfect match for Lupin, as the fastest growing, and largest independently owned acquirable pharmaceutical business in South Africa, why…
The chairman of PHARMISA reveals how pharmaceuticals has been designated as one of eight priority sectors of South African Government’s Industrial Policy Action Plan (IPAP), how South African life expectancy…
The CEO of Pierre Fabre for South Africa reveals how his focus has been on marketing the company brand locally, why the goal of the company is to develop business…
The EO of SAMED discusses recent regulations surrounding the medical device industry in South Africa, why South Africa remains the hub and the major gateway to Africa for medical devices…
The managing director of UTi Pharma reveals how UTi is no longer just an international forwarding company but covers a broad spectrum of activities; why as global business increases it…
The MD of Triclinium Clinical Development discusses how South Africa’s established First and Third World research opportunities and long-established GCP culture have made it a uniquely attractive country for clinical…
The country manager for BMS South Africa talks about the company’s first to market strategy, and how BMS has shifted the treatment paradigm for oncology in South Africa. Through our platform, we introduce the…
Iain Barton reveals how the acquisition of RTT Medical by IHS in 2013 has allowed Imperial to become the biggest pharma supply chain and general logistics services player on the African…
Peter Fuller provides us with an update on the integration of Covidien businesses, and explains how Medtronic is bringing innovation to South African patients and contributing to the improvement of the…
Adv. Leslie Sedibe, CEO of Proudly South African explains how the Proudly South African campaign aims to promote local products and services to ultimately address unemployment, and what his main…
See our Cookie Privacy Policy Here
